A notable advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://expressbookmark.com/story21308852/revolutionary-development-tirzepatide-strength-for-blood-sugar-control